Leaflet BONEFOS 60mg / ml concentrate for solution for infusion
Indicated for: bone metastases; tumor-induced hypercalcemia
Route of administration: infusion
Substance: clodronic acid (bisphosphonate)
ATC: M05BA02 (Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates)
Take this medicine on an empty stomach.
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
Clodronic acid is a bisphosphonate used to treat osteoporosis and hypercalcemia associated with bone metastases. It helps reduce bone loss by inhibiting osteoclast-mediated bone resorption.
It is commonly used in the treatment of cancer patients with bone metastases, helping to reduce pain and the risk of fractures. It can also be used to treat malignant hypercalcemia, a condition characterized by high calcium levels in the blood.
Clodronic acid is administered either orally or intravenously, depending on the medical indication. Side effects may include nausea, diarrhea, and, in rare cases, impaired kidney function. It is important for patients to strictly follow their doctor's recommendations to minimize risks.
Patients using clodronic acid should be periodically monitored to assess kidney function and blood calcium levels. It is contraindicated in cases of severe renal impairment.
General data about BONEFOS 60mg / ml
- Substance: clodronic acid
- Date of latest medicines list: 01-01-2014
- Product code: W53384001
- Concentration: 60mg / ml
- Pharmaceutical form: concentrate for solution for infusion
- Quantity: 5
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for clodronic acid
Concentrations available for clodronic acid
- 300mg/5ml
- 400mg
- 60mg/ml
- 800mg